title: Update on cytogenetic and molecular changes in myelodysplastic syndromes.
abstract: Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis and a high propensity to transform to acute myeloid leukemia (AML). In the pathogenesis of the disease, both gene mutations and cytogenetic changes play an important role. The latter have been integrated into prognostic scoring systems including the IPSS (International Prognostic Scoring System) and WPSS (World Health Organization [WHO] classification-based Prognostic Scoring System). In these systems and in multivariate analyses comparing clinical and genetic data, complex karyotypes are associated with a particularly poor prognosis. del(5q) plays a distinct role by classifying the only genetically defined WHO subtype. Also, due to advancement in technology such as whole genome sequencing, the number of known mutations occurring in MDS is steadily increasing. Important recent discoveries include mutations in EZH2, DNMT3A, ASXL1 and IDH1/2. Like TET2, the most commonly mutated gene in MDS, all are involved in epigenetic regulation. Mutations such as ASXL1, RUNX1, EZH2, ETV6/TEL and TP53 have an adverse impact on patient overall survival. Early evidence suggests that some mutations might influence treatment response, necessitating reassessment of the prognostic effect of genetic alterations in the light of every new treatment. This review discusses clinical and biological effects of the most common cytogenetic and molecular aberrations in patients with MDS.
authors: Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany. schlegelberger.brigitte@mh-hannover.de
authors: Brigitte
authors: B
authors: Schlegelberger
authors: Gudrun
authors: G
authors: Göhring
authors: Felicitas
authors: F
authors: Thol
authors: Michael
authors: M
authors: Heuser
mesh_terms: D002869:Chromosome Aberrations; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D006801:Humans; D059785:Karyotype; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000235:genetics* / Q000473:pathology; D011379:Prognosis